#United States #Austin #Inc. 5000 #RazorMetrics #Pharmacy Technology

RazorMetrics Ranked 18th in 2025 Inc. 5000 List

RazorMetrics, an innovator in pharmacy technology solutions, recently made headlines by debuting at the impressive rank of 18 on the 2025 Inc. 5000 list, recognizing the fastest-growing private companies in America. This prestigious list is a beacon for identifying the success stories of independent businesses across the nation, with past honorees including giants like Microsoft and Meta.

Acknowledging Growth and Impact

The recognition highlights not only RazorMetrics' outstanding growth but also the critical role it plays in addressing the widespread issue of medication affordability in the United States. In a market where nearly half of Americans struggle to afford prescribed medications, RazorMetrics stands out by providing scalable solutions that ease financial burdens.

Dr. Siva Mohan, the co-founder and president of RazorMetrics, emphasized the complications that fluctuating medication prices cause for patients and healthcare providers alike. This recognition by Inc. serves as further validation for their mission — enhancing accessibility and affordability in pharmaceutical care through innovative, physician-friendly tools designed to streamline treatment processes.

CEO Tom Dorsett also shared his excitement regarding the company's achievement. Ranking as the fastest-growing private company in the Austin metro area and the fifth fastest in the healthcare sector is not only an honor but also a significant milestone for Dorsett. His years as an entrepreneur have driven him to pursue scalable solutions that make medications more accessible while improving overall healthcare outcomes.

Growth Amid Challenges

The Inc. 5000 group of companies showcased extraordinary growth in a backdrop of economic uncertainty, achieving a remarkable median three-year revenue growth rate surpassing 1,500%. This achievement also contributed to the creation of nearly 50,000 jobs nationwide, highlighting the essential role these companies play in fueling economic dynamism.

“RazorMetrics is honored to earn such recognition, and we recognize the collective efforts of our amazing team that has made this progress possible. Change in the healthcare landscape is not just needed but imperative. We are thrilled to contribute meaningfully to this critical issue,” said Dorsett.

The journey towards recognition has been significant for RazorMetrics, marked by substantial accomplishments throughout the year. In April, the company published its 2025 State of Drug Access report, revealing alarming statistics where nearly half of Americans reported difficulty affording prescribed medications. This report underscores not just the challenges individuals face but also the urgent need for solutions in the pharmaceutical industry.

Moreover, the company’s co-founders received additional accolades as Ernst & Young named them as the 2025 Gulf South Award winners, recognizing their dedication to tackling rising drug costs effectively. Such accolades validate RazorMetrics' commitment to making a tangible difference in people's lives by ensuring they can access the medications they need.

Looking Ahead

When evaluating the path to their accomplishments, it’s crucial to note that the Inc. 5000 ranking is based on percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded by March 31, 2021, and must maintain independent, for-profit, U.S.-based operations. RazorMetrics exemplifies the innovative spirit that characterizes the Inc. 5000, marrying technology with healthcare to forge a new frontier in medicine, where affordability and accessibility are prioritized.

In conclusion, RazorMetrics’ debut on the Inc. 5000 list is a testament to the dedication of its team, the effectiveness of its solutions, and the critical need for innovation in confronting drug affordability issues in America. As they continue to advance their technology, their impact on the healthcare landscape will undoubtedly grow, helping to reshape how medications are accessed and utilized across the nation.